Notice – Release of ICH M9: Biopharmaceutics Classification System (BCS) Based Biowaivers

Description

Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance M9: Biopharmaceutics Classification System (BCS) Based Biowaivers.

Resources

Name Format Description Link
Notice – Release of ICH M9: Biopharmaceutics Classification System (BCS) Based Biowaivers HTML https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/multidisciplinary/notice-ich-m9-biopharmaceutics-classification-system-based-biowaivers.html
Notice – Release of ICH M9: Biopharmaceutics Classification System (BCS) Based Biowaivers HTML https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/international-conference-harmonisation/multidisciplinaire/avis-ich-m9-dispense-demonstration-bioequivalence-fondee-systeme-classification-biopharmaceutique.html

Tags

Topics

Categories